An increasing of arterial stiffness is the path physiological characteristic of hypertension. Cardio-ankle vascular index (CAVI) is a new index of arterial stiffness. In the present study, we investigated the relationship between CAVI and plasma lipids in hypertension subjects. A total of 542 subjects (male/female 336/206) from the Department of Vascular Medicine were divided into two groups: healthy group (n ¼ 402) and hypertension group (n ¼ 140). CAVI was measured with VS-1000 apparatus. Our results showed that the levels of CAVI, body mass index (BMI), fast blood glucose (FBG), uric acid (UA) and triglycerides (TGs) were significantly higher in the hypertension group than in the control group (all Po0.01). High-density lipoprotein cholesterol (HDL-C) was significantly lower in the hypertension group than in the control group (Po0.001). CAVI was positively correlated with FBG, UA, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and TG in the entire study group. Negative correlation between CAVI and HDL-C was found in the entire group even after adjusting for age, gender and blood pressure. In addition, there was negative correlation between CAVI and HDL-C in the control group. However, there was negative relational tendency between CAVI and HDL-C in hypertension subjects without significant difference. Multiple linear regression analysis showed that age, BMI, FBG, TG and heart rate were independent associating factors of CAVI in all subjects. Age, FBG and Cr were independent associating factors of CAVI in the hypertension group. Our present study showed that CAVI was significantly higher in hypertension subjects, and metabolic accompaniments might involve the increasing of arterial stiffness in hypertension patients.
INTRODUCTION
Arteriosclerosis is the basic pathophysiological change during the development of vascular-related diseases such as hypertension, diabetes mellitus, coronary artery disease (CAD) and metabolic syndrome and so on. Arterial stiffness is a strong predictor of future cardiovascular events and all-cause mortality. In addition, it is one of the earliest detectable manifestations of adverse structural and functional changes within the vessel wall during the development of arteriosclerosis. 1 Our previous studies also showed that arterial stiffness was positively correlated with pulse pressure and it was increased in hypertension patients with left ventricular hypertrophy. 2, 3 Cardio-ankle vascular index (CAVI), a new index of arterial stiffness, is recently developed by measuring the pulse wave velocity (PWV) and blood pressure. 4 Recent studies have showed that the CAVI is a reliable index of arterial stiffness in many vascular-related diseases. 5, 6 Our recent study found that CAVI was positively correlated with homocysteine in vascularrelated diseases. 7 Dyslipidaemia is characterized by elevated levels of triglyceride (TG) and LDL-C and reduced levels of high-density lipoprotein cholesterol (HDL-C), which has an important role in the development of atherosclerosis, and previous study showed that lipid abnormalities are common in newly diagnosed subjects with arterial hypertension. 8 However, there was little research between CAVI and dyslipidaemia in hypertension subjects. In the present study, we investigated the relationship between CAVI and dyslipidaemia in hypertension subjects.
MATERIALS AND METHODS Subjects
A total of 542 subjects (male/female 336/206) from the Department of Vascular Medicine,-from January 2012 to December 2013-were enrolled in our study. Subjects with: CADs, diabetes mellitus, heart failure, stroke, renal function impairment, liver function impairment, systemic inflammatory diseases, infectious diseases or cancer were excluded. They were divided into two groups: healthy group (n ¼ 402) and hypertension group (n ¼ 140). Hypertension was defined as blood pressure measurement X140/90 mm Hg in three occasions at rest. All participants gave their written informed consent. This study was approved by the ethics committee of the Health Science Center, Peking University.
The assessment of CAVI CAVI was recorded using a VaseraVS-1000 vascular screening system (Fukuda Denshi, Tokyo, Japan) with the participant resting in a supine position. Electrocardiogram electrodes were placed on both wrists, a microphone for detecting heart sounds was placed on the sternum and cuffs were wrapped around both the arms and ankles. After automatic measurements, obtained data were analyzed with a software (VaseraVS-1000 vascular screening system (Fukuda Denshi)), and the value of CAVI was obtained automatically. 6 Laboratory measurements Blood samples were drawn from an antecubital vein in the morning after overnight fasting and collected into vacuum tubes containing EDTA for the measurement of plasma lipid and lipoprotein levels. Fasting plasma glucose (FPG), total cholesterol (TC), HDL-C and TG levels were analyzed using colorimetric enzymatic assays with the use of an autoanalyzer (HITACHI-7170, Hitachi, Tokyo, Japan) at the Central Chemistry Laboratory of the Peking University Shougang Hospital. Low-density lipoprotein cholesterol (LDL-C) levels were calculated.
Statistical analysis
The differences between groups were analyzed with t-test and proportions were analyzed with w 2 test. Correlation coefficient was calculated to find linear relation between different variables using Spearman correlation coefficient. Multiple linear regressions were used to estimate the coefficients of the linear equation, involving independent variables that affected the value of the dependent variables. Values were shown as mean ± s.d. unless stand otherwise. Po0.05 (two-tailed) was considered statistically significant.
Ethical approval
This study was approved by the ethics committee of the Health Science Center, Peking University, China.
RESULTS

Clinical characteristics of the study participants
The clinical characteristics of the study participants are shown in Table 1 . Our results showed that the levels of CAVI, body mass index (BMI), fast blood glucose (FBG), uric acid (UA) and TG were significantly higher in the hypertension group than in the control group. HDL-C was significantly lower in the hypertension group than in the control group (1.23 ± 0.35 versus 1.40 ± 0.39 mmol l À 1 , Po0.001). There were no significant differences about TC and LDL-C between these two groups (5.42±1.17 versus 5.26 ± 1.07 mmol l À 1 , 3.08 ± 0.88 versus 2.98 ± 0.82 mmol l À 1 , respectively, both P40.05). There was significant difference in age and composition of gender between these two groups. In addition, the levels of blood pressure were significantly higher in hypertension subjects compared with the healthy group.
Pearson correlations between CAVI and metabolic markers
Next, we investigated the Pearson correlations between CAVI and metabolic markers and other variables in the entire group.
As shown in Table 2 , our results showed that CAVI was positively correlated with FBG, UA, TC, LDL-C and TG in the entire study group (r ¼ 0.263, Po0.001; r ¼ 0.176, Po0.001; r ¼ 0.161, Po0.001; r ¼ 0.098, P ¼ 0.024; r ¼ 0.192, Po0.001, respectively). Negative correlation between CAVI and HDL-C was found in the entire group (r ¼ À 0.157, Po0.001). In addition, there was negative correlation between CAVI and HDL-C in the control group (r ¼ À 0.117, P ¼ 0.020). However, there was negative relational tendency between CAVI and HDL-C in hypertension subjects without significant difference (r ¼ À 0.110, P ¼ 0.196).
As shown in Table 1 , there was significant difference about age, gender composition and blood pressure between these two groups. In addition, our further results showed that CAVI was positively correlated with FBG and TG after adjusting for age, gender and blood pressure in all the study subjects (r ¼ 0.108, P ¼ 0.013; r ¼ 0.108, P ¼ 0.013; respectively). There was negative correlation between CAVI and HDL-C after adjusting for age, gender and blood pressure in all the study subjects (r ¼ À 0.087, P ¼ 0.049).
Multiple linear regression analysis
Multiple linear regressions were used to estimate the coefficients of the linear equation, involving independent variables that affected the value of CAVI. As shown in Table 3 , our results showed that age, BMI, FBG, TG and heart rate were independent associating factors of CAVI in all subjects
In addition, age, BMI, HDL-C, TG, heart rate and pulse pressure were independent associating factors of CAVI in the healthy group 
DISCUSSION
Our present study showed that CAVI was significantly higher in hypertension subjects, and metabolic accompaniments might involve the increasing of arterial stiffness in hypertension patients.
An increase in arterial stiffness is not only a pathological status of hypertension but also a strong predictor for the cardiovascular morbidity and mortality caused by hypertension. 9 In addition, it can be measured by PWV, which is considered as the gold standard method suggested by the European Society of Hypertension/European Society of Cardiology guidelines. 10 However, PWV itself is essentially dependent on immediate blood pressure during measuring time. CAVI, a new index of arterial stiffness, is derived from stiffness parameter b. 6 The study of b1-and a1-adrenergic receptor blockers on CAVI showed that it is independent of blood pressure at measuring time, and CAVI could show the real effect of hypertension on the proper stiffness of the arterial wall. 11 The diagnostic accuracy of CADs was significantly higher in the CAVI than in the brachial ankle PWV, which suggested that CAVI had increased performance over brachial ankle PWV in predicting the CAD. 12, 13 Previous studies showed that CAVI is a useful clinical marker for evaluating atherosclerosis and arteriolosclerosis in patients with essential hypertension 14 and provides diastolic functional information in hypertensive patients. 15 In addition, our present study showed that CAVI was significantly higher in hypertension subjects, similar to our previous research. 16 In a cross-sectional study of 32 627 urban residents, Namekata et al. 17 showed that the CAVI method was a useful tool to screen persons with moderate to advanced levels of arteriosclerosis. Recent studies showed that CAVI increased significantly with the number of metabolic syndrome components, and CAVI was significantly decreased after weightreduction therapy through diet and exercise. [18] [19] [20] In addition, our present study showed that CAVI was positively correlated with blood pressure, FBG and TG in the entire group, similar to previous study. Above studies suggest that CAVI is a reliable evaluation index of arterial stiffness. 21 Dyslipidaemia is characterized by elevated levels of TG and LDL-C and reduced levels of HDL-C. In addition, it has an important role in the development of coronary atherosclerosis, and previous study showed that lipid abnormalities are common in newly presenting Nigerians with arterial hypertension. 8 A follow-up study showed that arterial stiffness was improved by low-dose atorvastatin therapy in patients with hypertension and hypercholesterolemia. 22 Gottsäter et al. 23 showed that there was negative association between HLD-C and aotic stiffness indicating the role of impaired lipid metabolism in the pathophysiology of arterial stiffness. Sacks showed that diabetic kidney disease is associated worldwide with higher levels of plasma TGs and lower levels of HDL-C among patients with good control of LDL-C, indicating the rationale for studying dyslipidemia treatment to prevent diabetic microvascular disease. 24 Heffernan et al. 25 found that subjects with a low HDL-C had significantly higher carotid artery stiffness in men with pre-hypertension. Vega et al. 26 showed that TG/HDL-C ratio is an index of heart disease mortality and of incidence of diabetes mellitus in a survival analysis of 39 447 men. In addition, our present study showed that CAVI was positively correlated with TG and negatively correlated with HDL-C. Some researchers suggested that HDL-C might be a therapeutic target in vascular-related diseases. 27 However, the effects of HDL-C on the endothelial function could be highly heterogeneous. HDL-C from CAD patients was more proinflammatory rather than anti-inflammatory. 28 Another study showed that HDL-C increasing therapy had no beneficial effect on coronary atherosclerosis progression. 29 In the present study, our results showed that CAVI was negatively correlated with HDL-C in the entire group (r ¼ À 0.157, Po0.001) and in healthy subjects (r ¼ À 0.117, P ¼ 0.020). However, there was negative tendency between CAVI and HDL-C in hypertension subjects without significant difference (r ¼ À 0.110, P ¼ 0.196). In addition, a recent study found that HDL-C from patients with type 2 diabetes mellitus and metabolic syndrome has substantially impaired endothelial-protective effects compared with HDL-C from healthy subjects. 30 However, our present study provided a basis for the relationship between lipid disorders and arterial stiffness in hypertension subjects to some extent. The abnormality of lipids should be emphasized during the therapy of hypertension. A major limitation of our study is its cross-sectional design; another limitation is that the subjects' numbers of each group were not balanced, therefore large sample and prospective study need to be investigated in future.
In conclusion, our present study showed that CAVI was significantly higher in hypertension subjects, and metabolic accompaniments might involve the increasing of arterial stiffness in hypertension patients. However, to be able to evaluate the prognostic value of CAVI, more prospective studies are needed.
What is known about topic?
Cardio-ankle vascular index (CAVI) is a new index of arterial stiffness independent of immediate blood pressure during measurement.
Recent studies have showed that CAVI was a reliable index of arterial stiffness in many vascular-related diseases. However, there was little research about CAVI and plasma lipids in hypertension subjects.
What this study adds?
